Shanghai Pharmaceuticals Holding stock in April (2026)

Shanghai Pharmaceuti...

SHSE:601607

¥ 17,16

+ ¥0,07 (0,41%)

17,16 ¥

+¥0,07 (0,41%)

End-of-day quote: 04/10/2026

Shanghai Pharmaceuticals Holding Stock Value

Analysts currently rate SHSE:601607 as Outperform.

Outperform

Shanghai Pharmaceuticals Holding Company Info

EPS Growth 5Y

-2,05%

Market Cap

¥57,48 B

Long-Term Debt

¥8,33 B

Annual earnings

N/A

Dividend

¥0,47

Dividend Yield

2,75%

Founded

1994

Industry

Health Care

Country

China

Website

Shanghai Pharmaceuticals Holding

ISIN Number

CNE000000C82

Website

http://www.sphchina.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

¥21,65

26.17%

Last Update: 04/11/2026

Analysts: 8

Highest Price Target ¥24,44

Average Price Target ¥21,65

Lowest Price Target ¥12,50

In the last five quarters, Shanghai Pharmaceuticals Holding’s Price Target has fallen from ¥22,33 to ¥21,27 - a -4,75% decrease. Ten analysts predict that Shanghai Pharmaceuticals Holding’s share price will increase in the coming year, reaching ¥21,65. This would represent an increase of 26,17%.

Top growth stocks in the health care sector (5Y.)

What does Shanghai Pharmaceuticals Holding do?

Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharmaceuticals) operates primarily in the pharmaceutical sector, focusing on manufacturing and distribution of pharmaceuticals, healthcare products, and other related services. The company has established itself as a key player in the Chinese pharmaceutical industry, engaging in a broad spectrum of activities that span research and development, manufacturing, wholesaling, and retailing of drugs, along with providing healthcare services. Busi...

Business Segments

The company has structured its operations into several key business segments that collectively contribute to its overall performance. These segments include:

Pharmaceutical Manufacturing

This segment forms the backbone of Shanghai Pharmaceuticals' operations. Its state-of-the-art manufacturing facilities adhere to the highest international standards, producing a wide range of generic and proprietary drugs across various therapeutic areas. The company emphasizes quality control and operational efficiency throughout the production process, ensuring that products meet stringent quality specifications before they are released to market.

Healthcare Services

This segment includes institutions that provide a range of medical services. Shanghai Pharmaceuticals focuses on enhancing healthcare access and efficiency through its comprehensive network of medical institutions. The company aims to improve patient outcomes by integrating pharmaceutical services with healthcare delivery, offering innovative solutions tailored to specific patient needs.

Wholesale and Retail Distribution

This segment includes wholesale operations that supply pharmaceuticals and healthcare products to hospitals, clinics, and retail pharmacies. The retail segment consists of pharmacies that operate under the company’s brand, providing consumers with access to a wide array of healthcare products, including over-the-counter medications, supplements, and personal care items. The retail strategy is geared toward maximizing consumer engagement and enhancing brand loyalty.

Research and Development

This segment discovers and develops new drugs and treatment modalities. The company's commitment to research is evident in its investment in advanced technologies and collaboration with academic institutions and research organizations. The goal is to transition innovative ideas to the marketplace, meeting the evolving needs of patients and healthcare providers.

Investment and Mergers & Acquisitions

This segment pursues opportunities for growth through investments in emerging pharmaceutical technologies and companies. This segment focuses on acquisitions that strengthen existing capabilities and open new markets, contributing to the overall competitiveness of Shanghai Pharmaceuticals in the global arena.

Business Strategy

The company employs a multi-faceted business strategy that focuses on growth, innovation, and international competitiveness. The company aims to implement a robust framework that reinforces its market position while addressing the evolving landscape of the pharmaceutical industry. Key elements of the strategy include:

Innovation-Driven Growth: The company prioritizes scientific and technological innovation, striving to develop next-generation therapies and enhance existing product lines. Investment in research and development is critical, and the aim is to establish a strong pipeline of innovative products that cater to unmet medical needs.

Market Expansion: The company seeks to expand its footprint in domestic and international markets. This includes developing strategies to enter new geographical areas and broadening the product portfolio to adapt to diverse markets, thereby increasing the company’s overall share and reach within the pharmaceutical sector.

Sustainability Initiatives: The company integrates sustainability into its core operations by adopting environmentally friendly practices in manufacturing and distribution. Shanghai Pharmaceuticals acknowledges the importance of corporate responsibility and aligns its goals with global sustainability initiatives.

Products and Services

The company offers an extensive range of products and services across pharmaceutical, healthcare, and distribution sectors. The portfolio includes:

Prescription Pharmaceuticals: The company produces a wide array of prescription medications, including antibiotics, pain management drugs, cardiovascular medications, and oncology products. The focus remains on high-quality production processes that meet regulatory requirements and deliver effective therapeutic solutions.

Over-the-Counter Medications: A significant portion of the product line comprises OTC medications that cater to consumer health needs. This includes analgesics, cold and flu medications, digestive aids, and dietary supplements, all designed to provide reliable and accessible healthcare options for consumers.

Biopharmaceuticals: Shanghai Pharmaceuticals is actively involved in the production of biopharmaceutical products, which leverage advanced biotechnological methods to create complex therapeutics. This includes monoclonal antibodies and recombinant proteins used in treating various diseases.

Retail Health Products: Through its pharmacy retail segment, the company offers a variety of consumer healthcare products, including skincare, personal hygiene items, and nutritional supplements. This service enhances customer engagement and provides comprehensive health solutions under one roof.

Healthcare Solutions: Beyond pharmaceuticals, the company partners with healthcare institutions to provide integrated healthcare services, enhancing the overall patient experience while ensuring effective medicinal usage.

Geographical Markets Served

Shanghai Pharmaceuticals operates within a diversified geographical landscape, focusing on the Chinese market, while also expanding its presence in international territories.

Seasonality

The pharmaceutical sector is generally less impacted by seasonality compared to other industries. However, Shanghai Pharmaceuticals observes variations in demand patterns, particularly for specific products. For instance, respiratory medications tend to see increased sales during colder months due to seasonal illnesses. The company is well-prepared to adjust its inventory and marketing strategies to accommodate these fluctuations, ensuring product availability aligns with consumer needs.

Customers

Shanghai Pharmaceuticals caters to a diverse clientele, which includes government healthcare institutions, private hospitals, retail pharmacies, and individual consumers.

Sales and Marketing

The company employs a multi-channel approach to sales and marketing, leveraging both traditional and digital platforms to reach consumers. Its distribution channels encompass direct sales to hospitals and healthcare institutions, partnerships with wholesalers, and retail outlets. The company’s marketing strategy focuses on consumer engagement and education, promoting its brand as a trusted provider of healthcare solutions.

History

Shanghai Pharmaceuticals Holding Co., Ltd. was founded in 1994. The company was incorporated in 1994.

Shanghai Pharmaceuticals Holding Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue distribution by sectors:** - **Pharmaceutical production:** approx. 60% - **Pharmaceutical trade:** approx. 35% - **Other services:** approx. 5% **TOP 3 markets and their percentage shares:** - **China:** approx. 75% - **USA:** approx. 10% - **Europe:** approx. 8% Shanghai Pharmaceutical...

At which locations are the company’s products manufactured?

**Production Sites:** Mainly in China (as of 2023) Shanghai Pharmaceuticals Holding Co., Ltd primarily produces its products in China. The company has several production facilities throughout the country that specialize in the manufacturing of pharmaceutical products and medical devices. In additi...

What strategy does Shanghai Pharmaceuticals Holding pursue for future growth?

**Revenue Growth:** 8.5% (2024) **Profit Growth:** 10.2% (2024) Shanghai Pharmaceuticals Holding Co., Ltd is pursuing a multi-pronged growth strategy focusing on innovation, expansion, and efficiency enhancement. A key element of the strategy is investing in research and development to expand the p...

Which raw materials are imported and from which countries?

**Main raw materials:** Active pharmaceutical ingredients (APIs), packaging materials **Countries of origin:** India, Germany, USA Shanghai Pharmaceuticals Holding Co., Ltd mainly imports active pharmaceutical ingredients (APIs) that are essential for the production of their medications. India is...

How strong is the company’s competitive advantage?

**Market share in China:** 10% (estimated, 2025) **Research & Development (R&D) expenses:** 5% of revenue (2024) **Industry comparison R&D:** Average 3% of revenue Shanghai Pharmaceuticals Holding Co., Ltd has a significant competitive advantage in the Chinese pharmaceutical indus...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** Estimated 45% (2025) **Insider Buys/Sells:** No significant transactions reported (2025) Shanghai Pharmaceuticals Holding Co., Ltd has an estimated institutional investor share of about 45%. This demonstrates the confidence of institutional investors in the compan...

What percentage market share does Shanghai Pharmaceuticals Holding have?

**Market share of Shanghai Pharmaceuticals Holding Co., Ltd:** 8% (estimated, 2025) **Top competitors and their market shares:** 1. **Sinopharm Group Co., Ltd:** 15% 2. **China Resources Pharmaceutical Group Limited:** 12% 3. **Shanghai Pharmaceuticals Holding Co., Ltd:** 8% 4. **Jiangsu Hengrui Me...

Is Shanghai Pharmaceuticals Holding stock currently a good investment?

**Revenue Growth:** 8.5% (2024) **Profit Growth:** 6.2% (2024) **Market Share in China:** 10% (2024) Shanghai Pharmaceuticals Holding Co., Ltd recorded a revenue growth of 8.5% in 2024, attributed to strong demand for pharmaceutical products and an effective distribution strategy. The 6.2% profit g...

Does Shanghai Pharmaceuticals Holding pay a dividend – and how reliable is the payout?

**Dividend Yield:** 3.5% (2024) **Dividend Growth:** 2% (annually, average over the last 5 years) **Payout Ratio:** 40% (2024) Shanghai Pharmaceuticals Holding Co., Ltd regularly pays dividends to its shareholders. The dividend yield of 3.5% in 2024 indicates an attractive payout compared to ma...

New support ticket

Explore

Shanghai Pharmaceuticals Holding Stock Value

Shanghai Pharmaceuticals Holding Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Shanghai Pharmaceuticals Holding do?

Shanghai Pharmaceuticals Holding Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Shanghai Pharmaceuticals Holding Stock Value

Shanghai Pharmaceuticals Holding Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Shanghai Pharmaceuticals Holding do?

Shanghai Pharmaceuticals Holding Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.